header
Local cover image
Local cover image
Image from OpenLibrary

Phenotypic characterization of myeloid derived suppressor cells in patients with breast cancer / Shimaa Abbas Ali Hussien ; Supervised Mervat Saad Elansary , Dina Mohamed Tawfik Koptan , Karim Kamal Mourice

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Shimaa Abbas Ali Hussien , 2021Description: 133 P. : charts , facsimiles ; 25cmOther title:
  • التوصيف المظهرى للخلايا النخاعية المثبطة فى المرضى المصابين بسرطان الثدى [Added title page title]
Subject(s): Online resources: Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology Summary: Background:Myeloid derived suppressor cells (MDSCs) inhibit adaptive immunity and support tumor progression by promoting tumor cell survival and metastasis. MDSCs may be involved in the pathogenesis of variouscancers. The purpose of this study wasto characterize the phenotype of MDSCs in a cohort ofEgyptian breast cancer patients and explore their possible associationwithtumor size, histopathology, hormonal markers and their levels in relation to neoadjuvant therapy intake. Methods:MDSC subsets were analyzedin peripheral blood samples by flow cytometry in 30 patients with malignant breast tumors, 10 patients with benign breast tumors and 10 healthy controls. Results:Total MDSCs, monocytic(M)-MDSCs and myelomono MDSCs were significantly higher in the patients with breast cancer compared to controls (p= 0.01, p= 0.001 and p<0.001, respectively), while immature MDSCs werelower in patients with malignancy compared to controls (p<0.001). No significant difference was observed between breast cancer patients and controlsregarding granulocytic(G)-MDSCs (p=0.1).We observed increased G-MDSC levels in patients with a tumorsize > 2 cm compared to patients with a tumor size < 2 cm(p=0.02) as well as patients with a positive family history of breast cancer compared to patients with negative family history of breast cancer (p=0.02). The frequency of myelomono MDSCs decreased (p=0.037) while the frequency of the granulocytic subset increased as the tumor grows.There was no difference in total MDSC levelsbetweenpatients with malignancy with/without pasthistory of breast cancer, distant metastasis, lymph nodes involvement, lymph vascular emboli, estrogen receptors, progesterone receptors, HER2/neu receptors andKi-67
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.Ph.D.2021.Sh.P (Browse shelf(Opens below)) Not for loan 01010110083786000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.07.Ph.D.2021.Sh.P (Browse shelf(Opens below)) 83786.CD Not for loan 01020110083786000

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology

Background:Myeloid derived suppressor cells (MDSCs) inhibit adaptive immunity and support tumor progression by promoting tumor cell survival and metastasis. MDSCs may be involved in the pathogenesis of variouscancers. The purpose of this study wasto characterize the phenotype of MDSCs in a cohort ofEgyptian breast cancer patients and explore their possible associationwithtumor size, histopathology, hormonal markers and their levels in relation to neoadjuvant therapy intake. Methods:MDSC subsets were analyzedin peripheral blood samples by flow cytometry in 30 patients with malignant breast tumors, 10 patients with benign breast tumors and 10 healthy controls. Results:Total MDSCs, monocytic(M)-MDSCs and myelomono MDSCs were significantly higher in the patients with breast cancer compared to controls (p= 0.01, p= 0.001 and p<0.001, respectively), while immature MDSCs werelower in patients with malignancy compared to controls (p<0.001). No significant difference was observed between breast cancer patients and controlsregarding granulocytic(G)-MDSCs (p=0.1).We observed increased G-MDSC levels in patients with a tumorsize > 2 cm compared to patients with a tumor size < 2 cm(p=0.02) as well as patients with a positive family history of breast cancer compared to patients with negative family history of breast cancer (p=0.02). The frequency of myelomono MDSCs decreased (p=0.037) while the frequency of the granulocytic subset increased as the tumor grows.There was no difference in total MDSC levelsbetweenpatients with malignancy with/without pasthistory of breast cancer, distant metastasis, lymph nodes involvement, lymph vascular emboli, estrogen receptors, progesterone receptors, HER2/neu receptors andKi-67

Issued also as CD

There are no comments on this title.

to post a comment.

Click on an image to view it in the image viewer

Local cover image